Testing effectiveness (Phase 2)Study completedNCT00377520
What this trial is testing
A Trial for Patients With Advanced/Recurrent Endometrial Cancer
Who this might be right for
NeoplasmsNeoplasms by SiteUrogenital Neoplasms+8 more
Eli Lilly and Company 27